Member

Login to your account, make a payment, see benefits and more.

Members

Manage Your Plan

Helpful Tools

Wellcare By Fidelis Care

Members
Providers

Login to your account, download forms, view auth grids and more.

Providers

Provider Resources

About Our Plans

Helpful Tools

Providers
Shop For a Plan

See plan benefits, coverage areas, get a quote and more.

Shop for a Plan

Our Plans

Helpful Tools

Wellcare By Fidelis Care

Shop for a Plan
AAA
HomeAbout usHealth EquityHealth Equity Alt

Health Equity

At Fidelis Care, we believe everyone should have the opportunity to live a healthy life. It’s our mission to ensure New Yorkers have access to high-quality healthcare, so they can get the care they need when they need it.

But many other factors contribute to an individual’s health and wellness beyond access to healthcare. Socioeconomic conditions can influence health risks and outcomes. Poverty, food insecurity, housing instability, education, employment, access to transportation and other circumstances contribute to health disparities among underserved and vulnerable populations.

Fidelis Care is committed to removing those barriers to health to improve access, quality, and affordability. It is an ongoing process that requires working together with our members, providers, and community-based organizations to support fair and just opportunities to equal access to healthcare.

Learn more about our different approaches to improve health equity:


Key partnerships

Wellness commitment to Buffalo Urban League

To nurture social entrepreneurship, facilitate wellness, and strengthen organizations focused on Black, Indigenous and People of Color in Buffalo’s East Side, Fidelis Care and the Centene Foundation donated $1.1 million to the Buffalo Urban League (BUL) to help establish its new headquarters and develop a Wellness and Entrepreneurial Center.

In addition, Fidelis Care partners with BUL through community programs and at events held in the city focused on health, family support and stabilization services, foster care, adoption, education, job training, employment, scholarships, and more.

Buffalo-Urban-League

Mental health alliance with The Jed Foundation

As part of our behavioral health efforts, Fidelis Care and the Centene Foundation awarded $1.1 million to The Jed Foundation (JED) to protect the mental health of New York State’s youth.

Through the funding, JED will expand its current services, providing at least five youth-serving community-based organizations (CBOs) with consultation or strategic planning services, including expert guidance, educational workshops, and training programs, equipping young people with life skills and connecting them to mental healthcare when they are in distress.

Fidelis-JED-Social


More Health Equity News


Fidelis Care Authorization Grids Effective July 1, 2026
5/28/2026 • Posted by Provider Relations in Provider News

The following section of the Fidelis Care authorization grids has been updated effective July 1, 2026.

           

The following codes have been updated on the Medicaid, CHP, Essential Plan, Ambetter Metal-Level Plans, and Medicare Authorization Grids and require prior authorization:

C9310 leucovorin calcium (avyxa), inj

J1289 narsoplimab-wuug, inj (Yartemlea)

J1577 immune globulin, inj (Qivigy)

J2361 depemokimab-ulaa, inj (Exdensur)

J2789 riboflavin 5'-phosphate, ophthalmic (Epioxahd/Epioxa)

J3386 etuvetidigene autotemcel, inj (Waskyra)

J3405 onasemnogene abeparvovec-brve, inj (Itvisma)

J9053 belantamab mafodotin-blmf, inj (Blenrep)

J9062 amivantamab and hyaluronidase-lpuj, inj (Rybrevant)

J9232 docetaxel (hospira), inj

Q5164 ustekinumab-hmny, inj (Starjemza)

Q5165 denosumab-mobz, inj (Oziltus)

Q5166 denosumab-desu, inj (Osvyrti/Jubereq)

Q5167 denosumab-qbde, inj (Enoby/Xtrenbo)

Q5168 ranibizumab-leyk, inj (Nufymco)

Q5169 pegfilgrastim-unne, inj (Amlupeg)

Q5170 aflibercept-boav, inj (Eydenzelt)

Q5171 denosumab-mobz, inj (Boncresa)

 

For Medicaid, Essential Plan, Ambetter Metal-Level Plans, and Medicare, the following codes have been added to the list of drugs that require NCH review:

C9310 leucovorin calcium (avyxa), inj

J9053 belantamab mafodotin-blmf, inj (Blenrep)

J9062 amivantamab and hyaluronidase-lpuj, inj (Rybrevant)

J9232 docetaxel (hospira), inj

Q5165 denosumab-mobz, inj (Oziltus)

Q5166 denosumab-desu, inj (Osvyrti/Jubereq)

Q5167 denosumab-qbde, inj (Enoby/Xtrenbo)

Q5169 pegfilgrastim-unne, inj (Amlupeg)

Q5171 denosumab-mobz, inj (Boncresa)

 

The following codes have been added to the TurningPoint authorization grid and require prior authorization:

93653  Cardiac Ablation

93654  Cardiac Ablation

93656  Cardiac Ablation

93580  Percutaneous Transcatheter Closure

 

Visit:  Authorization Grids